SUVRETTA CAPITAL MANAGEMENT, LLC - 22 Apr 2024 Form 3 Insider Report for Benitec Biopharma Inc. (BNTC)

Role
10%+ Owner
Signature
By: /s/Andrew Nathanson, Suvretta Capital Management, LLC, General Counsel & Chief Compliance Officer
Issuer symbol
BNTC
Transactions as of
22 Apr 2024
Net transactions value
$0
Form type
3
Filing time
02 May 2024, 17:27:51 UTC
Next filing
30 Sep 2024

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
holding BNTC Common stock, par value $0.0001 per share 1,470,179 22 Apr 2024 I F1, F2, F4
holding BNTC Common stock, par value $0.0001 per share 221,111 22 Apr 2024 I F1, F3, F4

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
holding BNTC Pre-Funded Warrants 22 Apr 2024 Common Stock 588,235 $0.001700 I F5, F6, F11, F12
holding BNTC Pre-Funded Warrants 22 Apr 2024 Common Stock 4,605,000 $0.000100 I F5, F7, F11, F12
holding BNTC Pre-Funded Warrants 22 Apr 2024 Common Stock 1,726,203 $0.000100 I F5, F8, F11, F12
holding BNTC Pre-Funded Warrants 22 Apr 2024 Common Stock 576,347 $0.000100 I F5, F9, F11, F12
holding BNTC Pre-Funded Warrants 22 Apr 2024 Common Stock 276,353 $0.000100 I F5, F10, F11, F12
holding BNTC Series 2 Common Warrants 22 Apr 2024 Common Stock 588,236 $1.93 I F6, F11, F12
holding BNTC Common Warrants 22 Apr 2024 Common Stock 4,605,000 $3.86 I F7, F11, F12
holding BNTC Common Warrants 22 Apr 2024 Common Stock 576,347 $3.86 I F9, F11, F12
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 See Exhibit 99.1
F2 See Exhibit 99.1
F3 See Exhibit 99.1
F4 See Exhibit 99.1
F5 See Exhibit 99.1
F6 See Exhibit 99.1
F7 See Exhibit 99.1
F8 See Exhibit 99.1
F9 See Exhibit 99.1
F10 See Exhibit 99.1
F11 See Exhibit 99.1
F12 See Exhibit 99.1

Remarks:

Exhibit List: ------------- Exhibit 99.1 - Explanation of Responses Exhibit 99.2 - Joint Filer Information Exhibit 99.3 - Joint Filers' Signatures